vimarsana.com

Latest Breaking News On - Institutional trading of teva pharmaceutical industries - Page 1 : vimarsana.com

Teva Pharmaceutical Industries (NYSE:TEVA) Upgraded at JPMorgan Chase & Co

JPMorgan Chase & Co. upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from an underweight rating to a neutral rating in a research note published on Friday, MarketBeat Ratings reports. JPMorgan Chase & Co. currently has $14.00 target price on the stock. Several other brokerages also recently weighed in on TEVA. The Goldman […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.